Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Hrzenjak Andelko |

Präsentationen bei wissenschaftlichen und nicht-wissenschaftlichen Veranstaltungen

Haas, D; Kröll, M; Dandachi, N; Dengler, M; Hrzenjak, A; Balic, M Modeling and overcoming clinically relevant resistance mechanisms to CDK4/6 inhibitor-based therapy in hormone receptor positive breast cancer cells
International Student Congress; Graz, AUSTRIA; . 2023. [Oral Communication]
FullText

 

Haitzmann, T; Bluemel, G; Sánchez-Murcia, PA; Ptaszek, A; Hrzenjak, A; Leithner, K Combined inhibition of gluconeogenesis and glycolysis suppresses lung cancer spheroid growth.
DocDay Medical University of Graz; 2023. [Oral Communication]

 

Hennecke, K; Dohr, KA; Windischofer, W; Plecko, B; Tokic, S; Hrzenjak, A Cloning and expression of a novel pahtogenic GLB1 variant doscovered in GM1 gangliosidosis patient
International Student Congress (ISC); June 9, 2023; Graz, AUSTRIA. 2023. [Poster]

 

Slanovc, J; Mikulcic, M; Jahn, N; Tabrizi-Wizsy, NG; Hrzenjak, A Prostaglandin 15d-PGJ2 is a potent compound for treatment of lung adenocarcinoma
WIEN KLIN WOCHENSCHR. 2022; 134(19-20): 724-724. [Poster]
Web of Science

 

Haitzmann, T; Bluemel, G; Planque, M; Madreiter-Sokolowski, CT; Olschewski, H; Hrzenjak, A; Graier, WF; Fendt, S-M; Leithner, K Gluconeogenesis via PCK2 promotes adaptability and redox balance in starved lung cancer cells and spheroids
EMBO Workshop: Cancer immunometabolism; NOV 29- DEC 1; Barcelona/virtual. 2021. [Oral Communication]

 

Lesko, J; Triebl, A; Stacher-Priehse, E; Fink-Neuböck, N; Lindenmann, J; Smolle-Jüttner F-M; Köfeler, HC; Hrzenjak, A; Olschewski, H; Leithner, K Phospholipid dynamics in lung cancer and normal lung ex vivo explants
Keystone Symposia: Tumor Metabolism and the Microenvironment; JAN 25-28; Virtual. 2021. [Poster]

 

Smolle, E; Leko, P; Stacher-Priehse, E; Brcic, L; El-Heliebi, A; Hofmann, A; Quehenberger, F; Hrzenjak, A; Popper, HH; Olschewski, H; Leithner, K Distribution and prognostic significance of gluconeogenesis and glycolysis in human lung cancer
VIB Conferences: Tumor Heterogeneity, Plasticity and Therapy; MAY 5-6, 2021; Virtual. 2021. [Poster]

 

Smolle, E; Leko, P; Stacher-Priehse, E; Brcic, L; El-Heliebi, A; Hofmann, L; Quehenberger, F; Hrzenjak, A; Popper, H; Olschewski, H; Leithner, K Expression Pattern and Prognostic Significance of Gluconeogenesis Enzymes in Lung Cancer.
J THORAC ONCOL. 2021; 16(3):S550-S550. [Poster]
Web of Science

 

Gabriele Grasmann, Mélanie Planque, Corina T Madreiter Sokolwski, Wolfgang F. Graier, Tobias Madl, Anna Springer, Andelko Hrzenjak, Horst Olschewski, Sarah- Maria Fendt, Katharina Leithner PCK2 balances TCA cycle flux and mitochondrial respiration to maintain the glutathione redox equilibrium in starved lung cancer cells.
. 2020; -Cell Bio Virtual 2020; DEC 2-16, 2020; Rockville, USA. [Oral Communication]

 

Gabriele Grasmann, Mélanie Planque, Corina T. Madreiter-Sokolowski, Wolfgang F. Graier, Tobias Madl, Anna Springer, Andelko Hrzenjak, Horst Olschewski, Sarah-Maria Fendt, Katharina Leithner PCK2 balances TCA cycle flux and mitochondrial respiration to maintain the redox equilibrium in starved lung cancer cells.
Program& Abstract Booklet, Life Science Tuesday #1, Lipids and Metabolism. 2020; -ÖGMBT; OCT 6, 2020; Vienna, Austria. [Oral Communication]

 

Smolle, E; Leko, P; Stacher-Priehse, E; Brcic, L; El-Heliebi, A; Hofmann, L; Quehenberger, F; Hrzenjak, A; Popper, H; Olschewski, H; Leithner, K Distribution and prognostic significance of gluconeogenic and glycolytic phenotypes in non-small cell lung cancer.
WIEN KLIN WOCHENSCHR. 2020; 132(19-20):621-622.-Annual Meeting of the Austrian Society of Pulmonology; OCT 14-16, 2020; virtual. [Oral Communication]
Web of Science

 

Smolle, E; Leko, P; Stacher-Priehse, E; Brcic, L; El-Heliebi, A; Hofmann, L; Quehenberger, F; Hrzenjak, A; Popper, H; Olschewski, H; Leithner, K Expression pattern and prognostic significance of gluconeogenesis enzymes in lung cancer.
Abstracts | IASLC 2020 World Conference on Lung Cancer | Singapore, Worldwide Virtual Event. 2020; 1211--IASLC - WCLC 2020 World Conference on Lung Cancer Singapore; JAN 28-31, 2020; Singapore (online). [Poster]
FullText

 

Joshi, L; Plastira, I; Bernhart, E; Koyani, C; Madl, T; Stryeck, S; Hrzenjak, A; Hallström, S; Sattler, W; Lysophosphatidic acid alters glucose metabolism via NRF2 mediated pathways in microglia
4th International Conference on ImmunoMetabolism: Molecular and Cellular Immunology of Metabolism; MAY 28 - JUN 2; Rhodes, GREECE. 2019. [Poster]

 

Leithner, K; The glycerol backbone of phospholipids derives from non-carbohydrate precursors in starved lung cancer cells
Forschungsfeld Krebsforschung; FEB 4, 2019; Graz. 2019. [Oral Communication]

 

Fadejeva, I; Bertsch, A; Panzitt, K; Leithner, K; Olschewski, H; Hrzenjak, A MicroRNA expression in A549 NSCLC cells and non-malignant bronchial epithelial cells under normoxic and hypoxic conditions
WIEN KLIN WOCHENSCHR. 2018; 130(19-20):601-602.-Jahrestagung der Österreichischen Gesellschaft für Pneumologie (ÖGP); OKT 18-20, 2018; Linz, AUSTRIA. [Poster]
Web of Science

 

Joshi, L; Plastira, I; Koyani, C; Bernhart, E; Madl, T; Stryeck, S; Hrzenjak, A; Hallstroem, S; Sattler, W Lysophosphatidic acid alters glucose metabolism in microglia
Doctoral Day 2018; NOV 28, 2018; Graz,AUSTRIA. 2018. [Poster]

 

Leithner, K; Triebl, A; Trötzmüller, M; Hinteregger, B; Leko, P; Wieser, B; Stacher, E; Valli, A; Prassl, R; Olschewski, A; Harris, AL; Köfeler, HC; Olschewski, H; Hrzenjak, A; Glyceroneogenesis is utilized for biomembrane synthesis in glucose-deprived cancer cells
Abstract book. 2017; 75--Beatson International Cancer Conference - "Feeding the Beast", the Metabolic Landscape of the Tumour and its Host; JUL 2-5, 2017; Glasgow, UK. [Poster]

 

Leithner, K; Triebl, A; Trötzmüller, M; Hinteregger, B; Leko, P; Wieser, B; Stacher, E; Valli, A; Prassl, R; Olschewski, A; Harris, AL; Köfeler, HC; Olschewski, O; Hrzenjak, A Glyceroneogenesis is utilized for biomembrane synthesis in glucose-deprived cancer cells
Abstract book. 2017; 25--Austrian Proteomics and Metabolomics Research Symposium; SEPT 6-8, 2017; Graz. [Oral Communication]

 

Leithner, K; Triebl, A; Trötzmüller, M; Hinteregger, B; Wieser, B; Stacher, E; Leko, P; Valli, A; Köfeler, HC; Olschewski, A; Harris, AL; Hrzenjak, A; Olschewski, H PCK2 is required for phosphatidylethanolamine synthesis in lung cancer cells facing nutrient shortage and for growth of subcutaneous xenografts in mice
Abstract book. 2017; 2030--Keystone Symposia - Tumor Metabolism: Mechanisms and Targets; March 5-9, 2017; Whistler, CANADA. [Poster]

 

Schilcher, I; Kern, S; Eichmann, T; Hrzenjak, A; Marsche, G; Frank, S Impact of Endothelial Lipase Overexpression on Cholesterol Efflux Capacity of Serum and HDL
Austrian Atherosclerosis Society ; MAY 12-13, 2017; St. Gilgen am Wolfgangsee. 2017. [Oral Communication]

 

Smolle, E; Bertsch, A; Leko, P; Hrzenjak, A; Stacher, E; Popper, HH; Olschewski, H; Leithner, K Expression of the gluconeogenic enzyme PCK2 in non small-cell lung cancer (NSCLC)
Doctoral Day Conference on cutting edge research @ MedUni - Abstractbook December 13th, 2017. 2017; 39--Doctoral Day Med Uni Graz, Conference on cutting edge research @ MedUni; DEC 13, 2017; Graz, AUSTRIA. [Poster]

 

Leithner, K; Hrzenjak, A; Triebl, A; Trötzmüller, M; Köfeler, HC; Olschewski, A; Harris, AL; Olschewski, H Adaptation to low glucose involves use of glutamine via glyceroneogenesis in lung cancer cells
Abstract book. 2016; P2027--Keystone Symposia: New Frontiers in Understanding Tumor Metabolism; FEB 21-25, 2016; Banff, Canada. [Poster]

 

Leithner, K; Hrzenjak, A; Triebl, A; Trötzmüller, M; Wieser, B; Köfeler, HC; Olschewski, A; Harris, AL; Olschewski, H PCK2 mediates glyceroneogenesis in lung cancer cells
LC-02. 2016; -8th ÖGMBT Annual Meeting; SEPT 12-14, 2016; Graz. [Oral Communication]

 

Schilcher, I; Hrzenjak, A; Eichmann, T; Stojakovic, T; Scharnagl, H; Marsche, G; Frank, S Impact of endothelial lipase overexpression on cholesterol efflux capacity of serum, apolipoproteinB- depleted serum and HDL
European Atherosclerosis Society Congress; MAY 29 - June 1; Innsbruck, AUSTRIA. 2016. [Poster]

 

Schilcher, I; Hrzenjak, A; Eichmann, T; Stojakovic, T; Scharnagl, H; Marsche, G; Frank, S IMPACT OF ENDOTHELIAL LIPASE OVEREXPRESSION ON CHOLESTEROL EFFLUX CAPACITY OF SERUM, APOLIPOPROTEIN B-DEPLETED SERUM AND HDL
ATHEROSCLEROSIS. 2016; 252: E207-E207.-Congress of the European-Atherosclerosis-Society (EAS); MAY 29-JUN 01, 2016; Innsbruck, AUSTRIA. Doi: 10.1016/j.atherosclerosis.2016.07.140 [Poster]
Web of Science FullText FullText_MUG

 

Schilcher, I; Kern, S; Hrzenjak, A; Eichmann, T; Stojakovic, T; Scharnagl, H; Marsche, G; Frank, S Impact of Endothelial Lipase overexpression on cholesterol efflux capacity of serum and apolipoprotein B-depleted serum as well as HDL
European Lipoprotein Club; SEPT 5-8, 2016; Tutzing, Germany. 2016. [Poster]

 

Schilcher, I; Kirsch, A; Kern, S; Hrzenjak, A; Eichmann, T; Marsche, G; Frank, S Endothelial Lipase modulates HDL-associated Paraoxonase 1 content and activity
European Lipoprotein Club; SEPT 5-8, 2016; Tutzing, Germany. 2016. [Poster]

 

Schilcher, I; Kirsch, A; Kern, S; Hrzenjak, A; Marsche, G; Frank, S Impact of Endothelial Lipase overexpression on HDL associated Paraoxonase 1 content and activity
ÖGMPT; SEPT 12-14, 2016; Graz, Austria. 2016. [Poster]

 

Fischer, C; Leithner, K; Wohlkoenig, C; Quehenberger, F; Bertsch, A; Olschewski, A; Olschewski, H; Hrzenjak, A Histone deacetylase inhibitor panobinostat reduces hypoxia-induced cisplatin resistance of non-small cell lung carcinoma via HIF-1α destabilisation
Wiener Klinische Wochenschrift. 2015; 127: 816-817.-Annual Meeting of the Austrian Society of Pneumology; Oct 15-17, 2015; Graz, Austria. [Poster]
Web of Science

 

Frille, A; Leithner, K; Hrzenjak, A; Olschewski, A; Olschewski, H; Wohlkoenig, C The influence of erythropoietin on growth and survival in non-small cell lung cancer cell lines
EUR RESPIR J. 2015; 46: Doi: 10.1183/13993003.congress-2015.PA4260
Web of Science FullText FullText_MUG

 

Leithner, K; Hrzenjak, A; Trötzmüller, M; Köfeler, HC; Harris, AL; Olschewski, A; Olschewski, H Beyond Wrburg effect: Adaptation to low glucose involves use of glutamine as alternative carbon source in lung cancer cells
Wiener Klinische Wochenschrift. 2015; 127: 816-816.-Annual Meeting of the Austrian Society of Pneumology; Oct 15-17, 2015; Graz, Austria. [Poster]
Web of Science

 

Fischer, C; Leithner K; Wohlkoenig, C; Quehenberger, F; Bertsch A; Olschewski O, Olschewski, A; Hrzenjak, A Reduction of hypoxia-induced cisplatin resistance of NSCLC cells via HIF-1alpha destabilization
Forschungsfeld Krebsforschung Mitgliederversammlung; SEPT 22, 2014; Graz, AUSTRIA. 2014. [Oral Communication]

 

Frank, S; Opresnik, S; Rao, SP; Hrzenjak, A; Hallstrom, S; Kozina, A; Sreckovic, I; Wadsack, CH; Holzer, M; Marsche, G; Birner-Gruenberger, R; Stojakovic, T; Scharnagl, H ENDOTHELIAL LIPASE ATTENUATES VASORELAXING CAPACITY OF HDL
ATHEROSCLEROSIS. 2014; 235(2): E45-E45. Doi: 10.1016/j.atherosclerosis.2014.05.102 [Poster]
Web of Science FullText FullText_MUG

 

Hrzenjak, A; Fischer, C; Leithner, K; Wohlkoenig, C; Quehenberger, F; Olschewski, A; Olschewski, H Panobinostat reduces hypoxia-related cisplatin resistance of non-small cell lung carcinoma cells via HIF-1alpha destabilization
European Journal of Cancer. 2014; 50 Supplement 5: S203-S203.-23rd Biennial Congress of the European Association for Cancer Research; JULY 5-8, 2014; Munich, Germany. [Poster]

 

Hrzenjak, A; Fischer, C; Leithner, K; Wohlkoenig, C; Quehenberger, F; Olschewski, A; Olschewski, H Panobinostat reduces hypoxia-related cisplatin resistance of non-small cell lung carcinoma cells via HIF-1alpha destabilization.
EUR J CANCER. 2014; 50: S203-S204. Doi: 10.1016/S0959-8049(14)50741-1 [Poster]
Web of Science FullText FullText_MUG

 

Kozina, A; Opresnik, S; Rao, S.P; Hrzenjak, A; Hallström, S; Sreckovic, I; Wadsack, Ch; Holzer, M; Marsche, G; Birner-Gruenberger, R; Stojakovic, T; Scharnagl, H; Frank, S Endothelial lipase attenuates vasorelaxing capacity of HDL
Book of Abstracts. 2014; -21st Annual Meeting of the Austrian Atherosclerosis Society; May 9-10, 2014; St. Gilgen/ Wolfgangsee. [Oral Communication]

 

Leithner, K; Hrzenjak, A; Olschewski, H PCK2 activation mediates an adaptive response to glucose depletion in lunger cancer
Forschungsfeld Krebsforschung Mitgliederversammlung; SEPT 22, 2014; Graz. 2014. [Oral Communication]

 

Leithner, K; Hrzenjak, A; Trötzmüller, M; Moustafa, T; Köfeler, HC; Wohlkoenig, C; Stacher, E; Harris, AL; Olschewski, A; Olschewski, H Role of the gluconeogenic enzyme phosphoenolpyruvate carboxykinase in lung cancer
European Journal of Cancer . 2014; 50 Supplement 5: S84-S84.-23rd Biennial Congress of the European Association for Cancer Research; JULY 5-8, 2014; Munich, Germany. [Poster]

 

Leithner, K; Hrzenjak, A; Trotzmuller, M; Moustafa, T; Kofeler, HC; Wohlkoenig, C; Stacher, E; Harris, AL; Olschewski, A; Olschewski, H; Role of the gluconeogenic enzyme phosphoenolpyruvate carboxykinase in lung cancer.
EUR J CANCER. 2014; 50: S84-S84.-EACR 23; Doi: 10.1016/S0959-8049(14)50315-2 [Poster]
Web of Science FullText FullText_MUG

 

Leithner, K; Hrzenjak, A; Trötzmüller, M; Moustafa, T; Köfeler, HC; Wohlkoenig, C; Stacher, E; Lindenmann, J; Harris, AL; Olschewski, A; Olschewski, H The gluconeogenic enzyme PCK2 mediates an adaptive response to glucose depletion in lung cancer
Abstract book. 2014; (X6):2015--Keystone Symposium Tumor Metabolism; March 16-21, 2014; Whistler, CANADA. [Poster]

 

Opresnik, S; Rao, S.P; Hrzenjak, A; Hallström, S; Kozina, A; Sreckovic, I; Wadsack, Ch; Holzer, M; Marsche, G; Birner-Gruenberger, R; Stojakovic, T; Scharnagl, H; Frank, S Endothelial Lipase Attenuates Vasorelaxing Capacity of HDL.
keine. 2014; -7th IAS Workshop on HDL; März 24-26, 2014; Rom, Italien. [Poster]

 

Fischer, C; Leithner, K; Wohlkoenig, C; Stacher, E; Olschewski, A; Olschewski, H; Hrzenjak, A Histone deacetylase inhibitor panobinostat reduces hypoxia-related cisplatin resistance in NSCLC cells by HDAC-mediated Hif alpha destabilization
EUR RESPIR J. 2013; 42:
Web of Science

 

Opresnik, S; Rao, SP; Hrzenjak, A; Hallström, S; Kozina, A; Sreckovic, I; Wadsack, Ch; Holzer, M; Marsche, G; Birner-Grünberger, R; Stojakovic, T; Scharnagl, H; Frank, S Endothelial lipase attenuates vasorelaxing capacity of HDL
43. Jahrestagung des Arbeitskreises ''Klinischer Lipidstoffwechsel'' Maikammer 2013; NOV 28-30, 2013; Maikammer, Deutschland. 2013. [Oral Communication]

 

Rao, S; Riederer, M; Hrzenjak, A; Hallström, S; Wadsack, Ch; Frank, S Impact of endothelial lipase on vascular reactivity
20th Annual Meeting-AAS of the Austrian Atherosclerosis Society; Mai 10-11, 2013; St.Gilgen/Wolfgangsee, AUSTRIA. 2013. [Oral Communication]

 

Wohlkoenig, C; Leithner, K; Hrzenjak, A; Olschewski, A; Olschewski, H Possible role of nuclear receptor nr4a1 in hypoxia-induced cisplatin resistance
EUR RESPIR J. 2013; 42:
Web of Science

 

Wohlkonig, C; Leithner, K; Hrzenjak, A; Olschewski, A; Olschewski, H; Cytosporone B, an nr4a1 specific cytotoxic agent, is not prone to hypoxia-induced apoptosis resistance in A549 cells.
WIEN KLIN WOCHENSCHR. 2013; 125(19-20):663-663.-ÖGP; OKT 24-26, 2013; Vienna, AUSTRIA. [Poster]
Web of Science

 

Crnkovic, S; Hrzenjak, A; Marsh, L; Olschewski, A; Kwapiszewska, G Origin Determination Of Remodeled Parenchymal Vessels In Mouse Pulmonary Hypertension Model Using EphrinB2 And EphB4
Am. J. Respir. Crit. Care Med.. 2012; (185):-American Thoracic Society 2012; May 2011; San Francisco. [Poster]

 

Leithner, K; Hrzenjak, A; Stacher, E; Trötzmüller, M; Köfeler, H; Zechner, R; Harris, AL; Olschewski, A; Olschewski, H Gluconeogenesis from lactate: an alternative metabolic pathway in lung cancer cells
Abstract book. 2012; -ZMF Day; NOV 8-9, 2012; Graz, AUSTRIA. [Oral Communication]

 

Leithner, K; Hrzenjak, A; Stacher, E; Trötzmüller, M; Köfeler, H; Zechner, R; Harris, AL; Olschewski, A; Olschewski, H Lung cancer cells utilize gluconeogenesis under glucose depletion
Doctoral Day of the Medical University of Graz; Dec 7, 2012; Graz, AUSTRIA. 2012. [Poster]

 

Leithner, K; Hrzenjak, A; Stacher, E; Zechner, R; Harris, AL; Olschewski A; et al Role of the gluconeogenic enzyme phosphoenolpyruvate carboxykinase in lung cancer cell survival under glucose depletion
Abstract CD of the Cell Symposium - Angiogenesis, Metabolic Regulation and Cancer Biology. 2012; P2.47--Cell Symposium - Angiogenesis, Metabolic Regulation and Cancer Biology; July 6-8, 2012; Leuven, Belgium. [Poster]

 

Leithner, K; Wohlkoenig, C; Stacher, E; Lindenmann, J; Hofmann, NA; Ebner, B; Quehenberger, F; Smolle-Juttner, FM; Philipsen, S; Popper, HH; Hrzenjak, A; Olschewski, A; Olschewski, H The metallopeptidase neprilysin is a hypoxia-induced prognostic factor in lung adenocarcinoma
EUR RESPIR J. 2012; 40:
Web of Science

 

Leithner, K; Wohlkoenig, C; Stacher, E; Lindenmann, J; Hofmann, NA; Ebner, B; Quehenberger, F; Smolle-Jüttner, F-M; Philipsen, S; Popper, HH; Hrzenjak, A; Olschewski, A; Olschewski, H The metallopeptidase neprilysin is a hypoxia-induced prognostic factor in lung adenocarcinoma
European Respiratory Journal . 2012; 40 Suppl. 56: P4167--22nd Annual Congress ofthe European Respiratory Society; SEPT 1-5, 2012; Vienna. [Poster]

 

Leithner, K; Wohlkoenig, C; Stacher, E; Lindenmann, J; Ebner, B; Guelly, C; Smolle-Jüttner, FM; Popper, HH; Hrzenjak, A; Olschewski, A; Olschewski, H Neprilysin is induced by hypoxia and is a prognostic factor in non-small cell lung cancer
WIEN KLIN WOCHENSCHR. 2011; 123(17-18):A24-A24.-Jahrestagung der Österreichischen Gesellschaft für Pneumologie; SEPT 8-10, 2011; Vienna, AUSTRIA. [Oral Communication]
Web of Science

 

Leithner, K; Wohlkoenig, C; Stacher, E; Lindenmann, J; Hofmann, NA; Ebner, B; Guelly, C; Smolle-Jüttner, F-M; Popper, HH; Hrzenjak, A; Olschewski, A; Olschewski, H Expression profiling identifies neprilysin as a hypoxia-regulated prognostic factor in non-small cell lung cancer
Doctoral Day; NOV 4, 2011; Graz, AUSTRIA. 2011. [Poster]

 

Leithner, K; Wohlkoenig, C; Stacher, E; Lindenmann, J; Smolle-Jüttner, F.-M.; Popper, HH; Hrzenjak, A; Olschewski, A; Olschewski, H Expression profiling in hypoxic non-small cell lung cancer explants reveals a four-gene hypoxia signature
European Respiratory Journal Supplement. 2011; P1964--European Respiratory Society Annual Congress; SEPT 24-28, 2011; Amsterdam, The Netherlands. [Poster]

 

Wohlkoenig, C; Leithner, K; Hrzenjak, A; Olschewski, A; Olschewski, H Down-regulation of the pro-apoptotic BCL-2 family member protein Bax by hypoxia may contribute to hypoxia-induced chemotherapy resistance in A549 lung cancer cells
WIEN KLIN WOCHENSCHR. 2011; 123(17-18):A33-A33.-Jahrestagung der Österreichischen Gesellschaft für Pneumologie; SEPT 8-10, 2011; Vienna, AUSTRIA. [Oral Communication]
Web of Science

 

Frille, A; Wohlkoenig, C; Leithner, K; Hrzenjak, A; Olschewski, A; Olschewski, H. The influence of erythropoietin on proliferation in lung cancer cell lines
Wiener Klinische Wochenschrift2010; 122(21-2):A51--Jahrestagung 2010 der Österreichischen Gesellschaft für Pneumologie; OKT 7-9, 2010; Graz, AUSTRIA. [Poster]
Web of Science

 

Hrzenjak, A; Moinfar, F; Kremser, ML; Strohmeier, B; Petru, E; Zatloukal, K; Denk, H Histone deacetylase inhibitor vorinostat suppresses the growth of uterine sarcomas in vitro and in vivo
EJC SUPPL. 2010; 8(5): 248 Doi: 10.1016/S1359-6349(10)71055-7
Web of Science FullText FullText_MUG

 

Leithner, K; Wohlkoenig, C; Katschnig, AM; Stacher, E; Lindenmann, J; Smolle-Jüttner, F-M; Popper, HH; Hrzenjak, A; Olschewski, A; Olschewski, H Expression of key enzymes for gluconeogenesis and glycogen deposition in lung cancer
Abstract book, 2010; P17--Joint ZMF and Doctoral Days; NOV 4-6, 2010; Graz, AUSTRIA. [Poster]

 

Leithner, K; Wohlkoenig, C; Stacher, E; Lindenmann, J; Smolle-Juttner, F; Popper, HH; Hrzenjak, A; Olschewski, A; Olschewski, H Constitutive expression of carbonic anhydrase IX in hypoxic and normoxic non-small cell lung cancer fragments
EJC SUPPL. 2010; 8(5): 192 Doi: 10.1016/S1359-6349(10)70999-X [Poster]
Web of Science FullText FullText_MUG

 

Leithner, K; Wohlkoenig, C; Stacher, E; Lindenmann, J; Smolle-Juttner, FM; Popper, HH; Hrzenjak, A; Olschewski, A; Olschewski, H Expression of key enzymes for gluconeogenesis and glycogen deposition in lung cancer
WIEN KLIN WOCHENSCHR. 2010; 122(21-22): A50-A50. [Poster]
Web of Science

 

Leithner, K; Wohlkoenig, C; Stacher, E; Lindenmann, J; Smolle-Jüttner, F-M; Popper, HH; Hrzenjak, A; Olschewski, A; Olschewski, H Expression of carbonic anhydrase IX splice variants in a novel ex vivo lung cancer model for hypoxic adaptation
Abstract book, 2010; V19--Joint ZMF and Doctoral Days; NOV 4-6, 2010; Graz, AUSTRIA. [Oral Communication]

 

Riederer,M;Ojala,P;Hrzenjak,A;Tritscher,M;Hermannson,M;Watzer,B;Schweer,H;Desoye,G;Heinemann,A;Frank,S Acyl chain-dependent effect of lysophosphatidylcholine on prostacyclin production
Austrian atherosclerosis society meeting; Mai 7-8, 2010; St.Gilgen, Austria. 2010. [Oral Communication]

 

Wohlkoenig, C; Leithner, K; Hrzenjak, A; Olschewski, A; Olschewski, H Blocking autocrine secreted vascular endothelial growth factor does not enhance cisplatin-induced apoptosis in non-small cell lung cancer cell lines
Wiener Klinische Wochenschrift 2010; 122(21-2):A53--Jahrestagung 2010 der Österreichischen Gesellschaft für Pneumologie; OKT 7-9, 2010; Graz. [Oral Communication]
Web of Science

 

Wohlkoenig, C; Leithner, K; Hrzenjak, A; Olschewski, A; Olschewski, H Interfering with autocrine vascular endothelial growth factor signalling does not reverse hypoxia-induced cisplatin resistance in non-small cell lung cancer cell lines.
Magazine of European Medical Oncology. 2010; 3 Suppl 02/10: -P18--Pneumoupdate; JUN 17-19; Innsbruck, AUSTRIA. [Poster]

 

Wohlkoenig, C; Leithner, K; Hrzenjak, A; Olschewski, A; Olschewski, H Autocrine vascular endothelial growth factor signaling has no influence on the apoptosis induction by cisplatin in non-small cell lung cancer cell lines
EJC SUPPL. 2010; 8(5): 538 Doi: 10.1016/S1359-6349(10)71339-2 [Poster]
Web of Science FullText FullText_MUG

 

Zabini, D; Bálint, Z; Hrzenjak, A; Klepetko, W; Lang, I; Olschewski, H; Olschewski, A Altered calcium homeostasis of endothelial cells involved in chronic thromboembolic pulmonary hypertension.
EMBO Conference Cellular Signaling & Molecular Medicine; MAY 21-26, 2010; Cavtat/Dubrovnik, Croatia. 2010. [Poster]

 

Leithner, K; Wohlkoenig, C; Li, Y; Tang, B; Nagaraj, C; Stacher, E; Bálint, Z; Lindenmann, J; Hrzenjak, A; Popper, HH; Olschewski, A; Olschewski, H Expression of TASK-1 and TASK-3 channels in non-small cell lung cancer
Abstract Book. 2009; P44--Joint ZMF and Doctoral Days; NOV 5-6; Graz, Austria. [Poster]

 

Leithner, K; Wohlkoenig, C; Stacher, E; Lindenmann, J; Popper, HH; Hrzenjak, A; Olschewski, A; Olschewski, H Moderate hypoxia induces hypoxic adaptation in an ex-vivo non-small cell lung cancer model
Wiener Klinische Wochenschrift 2009; 121(17-1):A50--ÖGP Annual Congress; JUN 11-13; Salzburg, AUSTRIA. [Poster]
Web of Science

 

Leithner, K; Wohlkoenig, C; Stacher, E; Lindenmann, J; Popper, HH; Hrzenjak, A; Olschewski, A; Olschewski, H A novel ex-vivo model for the evaluation of hypoxic adaptation in non-small cell lung cancer using surgery explants
European Respiratory Journal.2009; 34(S53):30s--Annual Conference of the European Respiratory Society; SEPT 12-16, 2009; Vienna, AUSTRIA. [Poster]

 

Marsche, G; Frank, S; Hrzenjak, A; Holzer, M; Heinemann, A; Öttl, K Advanced oxidation protein products are antagonists of the HDL receptor SR-BI
Circulation Research2009; 104(6):750-757.-15th Scientific Symposium of the Austrian Pharmacological Society (APHAR) ; NOV 19-21, 2009; Graz, Austria. (ISBN: 0009-7330 ) [Oral Communication]

 

Nußhold, C; Üllen, A; Waltl, S; Kratzer, I; Reicher, H; Bernhart, E; Hermetter, A; Kollroser, M; Rechberger, G; Köfeler, H; Hackl, H; Trajanoski, Z; Hrzenjak, A; Malle, E; Sattler, W Hypochlorite-modified shingomyelin mediates cytotoxicity and pronounced proteomic alterations in PC12 cells.
6th International Human Peroxidase Meeting 2009; April 19-22, 2009; Chapel Hill, NC, USA. 2009. [Poster]

 

Nußhold, C; Üllen, A; Waltl, S; Kratzer, I; Reicher, H; Bernhart, E; Hermetter, A; Kollroser, M; Rechberger, G; Köfeler, H; Hackl, H; Trajanoski, Z; Hrzenjak, A; Malle, E; Sattler, W Hypochlorite-modified shingomyelin mediates cytotoxicity and pronounced proteomic alterations in PC12 cells.
7th Euro Fed Lipid Congress; Oktober 18-21, 2009; Graz, AUSTRIA. 2009. [Poster]

 

Wohlkoenig, C; Leithner, K;Li, Y;Tang, B;Hrzenjak, A;Olschewski, A;Olschewski, H Blocking vascular endothelial growth factor does not reverse hypoxia-induced cisplatin resistance in A549 non-small cell lung cancer cells
Abstract Book, V162009; -Joint ZMF and Doctoral Days; NOV 5-6, 2009; Graz, AUSTRIA. [Oral Communication]

 

Wohlkoenig, C;Leithner, K;Stacher, E;Lindenmann, J;Popper, HH;Hrzenjak, A;Olschewski, A;Olschewski, H An ex-vivo tumor fragment model to study the effects of hypoxia on non-small cell lung cancer (NSCLC).
Abstract Book, P452009; -Joint ZMF and Doctoral Days; NOV 5-6, 2009; Graz, AUSTRIA. [Poster]

 

Zabini, D; Bálint, Z; Graier, WF; Hrzenjak, A; Olschewski, H; Olschewski, A Double-stranded RNA affects the TRPC channel expression in human pulmonary artery endothelial cells
WIEN KLIN WOCHENSCHR. 2009; 121(17-18):A57-A58.-ÖGP; JUN 11-13, 2009; Salzburg, AUSTRIA. [Oral Communication]
Web of Science

 

Zabini, D; Bálint, Z; Graier, WF; Hrzenjak, A; Olschewski, H; Olschewski, A Double-stranded RNA affects the TRPC channel expression in human pulmonary artery endothelial cells
MEMO - Magazine of European Medical Oncology, Proceedings of Pneumoupdate 2009; 2 (Sup4):14-14.-Pneumo-Update 2009; JUN 19-20, 2009; Innsbruck, AUSTRIA. [Poster]

 

Frank, S; Riederer, M; Gauster, M; Hrzenjak, A Endothelial Lipase: Modulator of HDL structure and function and generator of bioactive lipids
Scientific meeting: ''50 years molecular biology in Croatia'' ; Nov 20-21, 2008; Zagreb, Croatia. 2008. [Keynote lecture]

 

Mahajan, V; Kashofer, K; Hrzenjak, A; Abuja, PM; Denk, H; Zatloukal, K Molecular Pathogenesis of Liver Disease Steatoheapatitis - Role of p62 as a Stress Modulator.
1st Doctoral Day of the Medical University of Graz; OCT 15, 2008; Graz, AUSTRIA. 2008. [Poster]

 

Mahajan, V; Kashofer, K; Hrzenjak, A; Abuja, PM; Denk, H; Zatloukal, K Molecular Pathogenesis of Liver Disease Stetaohepatitis - Role of p62 as a Stress Modulator.
ZMF Research Day; NOV 12, 2008; Graz, AUSTRIA. 2008. [Poster]

 

Riederer, M; Gauster,M;Hrzenjak,A;Frank,S Endothelial lipase:modulator of HDL structure and function and generator of bioactive lipids.
50 years of molecular biology in Croatia; NOV 20-21,2008; Zagreb, CROATIA. 2008. [Keynote lecture]
FullText

 

Hrzenjak, A; Moinfar, F; Kremser, ML; Strohmeier, B; Staber, PB; Zatloukal, K; Denk, H Valproate inhibition of histone deacetylase 2 affects differentiation and decreases proliferation of endometrial stromal sarcoma cells
Frühjahrstagung der Österreichischen Gesellschaft für Pathologie; 8.-10. März 2007; Vienna, AUSTRIA. 2007. [Oral Communication]

 

Hrzenjak, A; Moinfar, F; Kremser, ML; Strohmeier, B; Zatloukal, K; Denk, H Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, selectively induces growth suppression and cell death of endometrial stromal sarcoma cells in vitro
VIRCHOWS ARCHIV. 2007; 451(2):401-401.-21th European Congress of Pathology; SEPT 8-13, 2007; Istanbul, Turkey. [Oral Communication]
Web of Science

 

Hrzenjak, A; Moinfar, F; Kremser, ML; Strohmeier, B; Zatloukal, K; Denk, H Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, selectively induces growth suppression and cell death of endometrial stromal sarcoma cell in vitro.
15th International Meeting of the European Society of Gynaecological Oncology (ESGO); October 28 - November 1, 2007; Berlin, GERMANY. 2007. [Poster]

 

Pichler, M; Mischinger, HJ; Ratschek, M; Hatz, M; Hrzenjak, A; Zatloukal, K A real-time qPCR-based assay for assessment of mRNA quality derived from paraffin-embedded tissues
PATHOL RES PRACT. 2007; 203(5):396-396.-91. Jahrestagung der Deutschen Gesellschaft für Pathologie.; MAY 30 - JUN 2, 2007; Magedeburg, GERMANY. [Poster]
Web of Science

 

Staber, PB; Vesely, P; Ott, R; Haq, N; Linkesch, W; Schauer, S; Hrzenjak, A; Kenner, L; Dirks, W; Kadin, ME; Sternberg, DW; Hoefler, G NPM-ALK fusion tyrosine kinase of anaplastic large cell lymphoma exerts its transforming potential by increasing translation of JUNB through mTOR and S6K1.
BLOOD. 2006; 108(11): 414A-415A. Doi: 10.1182/blood.V108.11.1428.1428 [Poster]
Web of Science FullText FullText_MUG

 

Vesely, P; Staber, PB; Ott, R; Pinent, M; Linkesch, W; Schauer, S; Hrzenjak, A; Kadin, ME; Sternberg, DW; Hoefler, G NPM-ALK converts JUNB from a tumor suppressor to an oncogene.
BLOOD. 2006; 108(11): 419A-420A. Doi: 10.1182/blood.V108.11.1448.1448 [Poster]
Web of Science FullText FullText_MUG

 

Hrzenjak, A; Frank, S; Zhou, Y; Van Berkel, T; Kostner, GM Galactose specific asialo glycoprotein receptor is involved in lipoprotein(a) catabolism
ATHEROSCLER SUPPL 2003 4: 284-284. Doi: 10.1016/S1567-5688(03)91214-1
Web of Science FullText FullText_MUG

 

Kostner, GM; Hrzenjak, A; Frank, S; Wo, X The catabolism of Lp(a)
ATHEROSCLER SUPPL 2003 4: 269-269. Doi: 10.1016/S1567-5688(03)91154-8
Web of Science FullText FullText_MUG

 

Panzenboeck, U; Balazs, Z; Sovic, A; Hrzenjak, A; Wintersperger, A; Sattler, W LXR-dependent autoregulation of `reverse sterol transport’ at an in vitro blood-brain barrier.
2nd international symposium on ‘PPARs: from basic science to clinical applications’; MAR 19-22; Florence, ITALY. 2003. [Oral Communication]

 

Sovic, A, Panzenboeck U, Balazs Z, Goti D, Hrzenjak A, Kostner G M, and Sattler W A role of scavenger receptor BI, endothelial lipase and fatty acid translocase/CD36 in PUFA supply at the blood-brain barrier.
2nd international symposium on ‘PPARs: from basic science to clinical applications’; Mar 19-22, 2003; Florence, ITALY. 2003. [Oral Communication]

 

Panzenboeck, U; Balazs, Z; Leibnitz, B; Wintersperger, A; Hrznjak, A; Levak-Frank, S; Sattler, W ‘Reverse sterol transport’ by microcapillary endothelial cells constituting the blood-brain barrier.
9. Jahrestagung der Österreichischen Atherosklerosegesellschaft (AAS).; May, 2002; 2002. [Oral Communication]

 

Panzenboeck, U; Balazs, Z; Sovic, A; Hrzenjak, A; Levak-Frank, S; Sattler, W Roles of ABCA1 and SR-BI during (oxy)sterol transport from brain capillary endothelial cells of the blood-brain barrier.
25th conference of the European Lipoprotein Club; Sep 9-12, 2002; Tutzing, GERMANY. 2002. [Oral Communication]

 

Panzenboeck, U; Balazs, Z; Wintersperger, A; Hrzenjak; A, Kostner, GM; Sattler, W Roles of ABCA1 and SR-BI during reverse sterol transport by brain capillary endothelial cells of the blood-brain barrier.
73rd Congress of the European Atherosclerosis Society (EAS); July, 2002; Salzburg, AUSTRIA. 2002. [Oral Communication]

 

Panzenboeck, U; Balazs, Z; Wintersperger, A; Hrzenjak, A; Levak-Frank, S; Sattler, W ‘Reverse sterol transport’ by capillary endothelial cells constituting the blood-brain barrier.
3rd Forum of European Neuroscience (Federation of the European Neuroscience Society); JUL 13-17, 2002; Paris, FRANCE. 2002. [Poster]

 

Hrzenjak, A; Frank, S; Kostner, GM Expression, purification and in vitro refolding of kringle IV-type 6 and kringle V of human apolipoprotein-(a)
ATHEROSCLEROSIS 1999 144: 105-105. Doi: 10.1016/S0021-9150(99)80404-3
Web of Science FullText FullText_MUG

 

↑ Seitenanfang / Navigation

© Med Uni Graz • Impressum